These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29532543)

  • 1. Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infection.
    Carnahan RM; Kuntz JL; Wang SV; Fuller C; Gagne JJ; Leonard CE; Hennessy S; Meyer T; Archdeacon P; Chen CY; Panozzo CA; Toh S; Katcoff H; Woodworth T; Iyer A; Axtman S; Chrischilles EA
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):731-739. PubMed ID: 29532543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users.
    Carnahan RM; Gagne JJ; Hampp C; Leonard CE; Toh S; Fuller CC; Hennessy S; Hou L; Cocoros NM; Panucci G; Woodworth T; Cosgrove A; Iyer A; Chrischilles EA
    Pharmaceut Med; 2019 Feb; 33(1):29-43. PubMed ID: 31933271
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Teng C; Reveles KR; Obodozie-Ofoegbu OO; Frei CR
    Int J Med Sci; 2019; 16(5):630-635. PubMed ID: 31217729
    [No Abstract]   [Full Text] [Related]  

  • 4. A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.
    McConeghy KW; Soriano MM; Danziger LH
    Pharmacotherapy; 2016 Oct; 36(10):1095-1101. PubMed ID: 27582058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile arising in a patient with hidradenitis suppurativa on clindamycin and rifampin.
    Bessaleli E; Scheinfeld N
    Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successional Dynamics in the Gut Microbiome Determine the Success of
    Jurburg SD; Cornelissen JJBWJ; de Boer P; Smits MA; Rebel JMJ
    Front Cell Infect Microbiol; 2019; 9():271. PubMed ID: 31448240
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic-Specific Risk for Community-Acquired
    Zhang J; Chen L; Gomez-Simmonds A; Yin MT; Freedberg DE
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0112922. PubMed ID: 36377887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis.
    Vardakas KZ; Trigkidis KK; Boukouvala E; Falagas ME
    Int J Antimicrob Agents; 2016 Jul; 48(1):1-10. PubMed ID: 27216385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
    Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
    J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Community-Associated Clostridium difficile Infection in Children.
    Adams DJ; Eberly MD; Rajnik M; Nylund CM
    J Pediatr; 2017 Jul; 186():105-109. PubMed ID: 28396027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
    DiDiodato G; McArthur L
    PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
    Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
    JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis.
    Deshpande A; Pasupuleti V; Thota P; Pant C; Rolston DD; Sferra TJ; Hernandez AV; Donskey CJ
    J Antimicrob Chemother; 2013 Sep; 68(9):1951-61. PubMed ID: 23620467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Propensity Score Analysis of Clostridium difficile Infection among Adult Trauma Patients.
    Gabriel V; Grigorian A; Phillips JL; Schubl SD; Barrios C; Pejcinovska M; Won E; Nahmias J
    Surg Infect (Larchmt); 2018 Oct; 19(7):661-666. PubMed ID: 30204556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
    Na'amnih W; Adler A; Miller-Roll T; Cohen D; Carmeli Y
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1281-1288. PubMed ID: 29627951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
    Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
    J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.